These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25024388)

  • 1. Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses.
    Dadaglio G; Fayolle C; Zhang X; Ryffel B; Oberkampf M; Felix T; Hervas-Stubbs S; Osicka R; Sebo P; Ladant D; Leclerc C
    J Immunol; 2014 Aug; 193(4):1787-98. PubMed ID: 25024388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
    Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
    Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.
    Ross PJ; Lavelle EC; Mills KH; Boyd AP
    Infect Immun; 2004 Mar; 72(3):1568-79. PubMed ID: 14977963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death.
    Boyd AP; Ross PJ; Conroy H; Mahon N; Lavelle EC; Mills KH
    J Immunol; 2005 Jul; 175(2):730-8. PubMed ID: 16002668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells.
    Hickey FB; Brereton CF; Mills KH
    J Leukoc Biol; 2008 Jul; 84(1):234-43. PubMed ID: 18401006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L; Simsova M; Jarvis Z; Brodin P; Rojas MJ; Bauche C; Nouzé C; Ladant D; Cole ST; Sebo P; Leclerc C
    Infect Immun; 2006 Apr; 74(4):2128-37. PubMed ID: 16552042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c + CD8 alpha -CD11bhigh dendritic cells.
    Guermonprez P; Fayolle C; Rojas MJ; Rescigno M; Ladant D; Leclerc C
    Eur J Immunol; 2002 Nov; 32(11):3071-81. PubMed ID: 12385027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.
    Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B
    Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming.
    Schlecht G; Loucka J; Najar H; Sebo P; Leclerc C
    J Immunol; 2004 Nov; 173(10):6089-97. PubMed ID: 15528345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis.
    Dunne A; Ross PJ; Pospisilova E; Masin J; Meaney A; Sutton CE; Iwakura Y; Tschopp J; Sebo P; Mills KH
    J Immunol; 2010 Aug; 185(3):1711-9. PubMed ID: 20610650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MyD88 Signaling Regulates Steady-State Migration of Intestinal CD103+ Dendritic Cells Independently of TNF-α and the Gut Microbiota.
    Hägerbrand K; Westlund J; Yrlid U; Agace W; Johansson-Lindbom B
    J Immunol; 2015 Sep; 195(6):2888-99. PubMed ID: 26259586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo.
    Fayolle C; Bauche C; Ladant D; Leclerc C
    Vaccine; 2004 Dec; 23(5):604-14. PubMed ID: 15542180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.
    Fayolle C; Osickova A; Osicka R; Henry T; Rojas MJ; Saron MF; Sebo P; Leclerc C
    J Virol; 2001 Aug; 75(16):7330-8. PubMed ID: 11462005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-beta, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo.
    De Trez C; Pajak B; Brait M; Glaichenhaus N; Urbain J; Moser M; Lauvau G; Muraille E
    J Immunol; 2005 Jul; 175(2):839-46. PubMed ID: 16002681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells.
    Svedova M; Masin J; Fiser R; Cerny O; Tomala J; Freudenberg M; Tuckova L; Kovar M; Dadaglio G; Adkins I; Sebo P
    Immunol Cell Biol; 2016 Apr; 94(4):322-33. PubMed ID: 26437769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes.
    Rathinam VA; Appledorn DM; Hoag KA; Amalfitano A; Mansfield LS
    Infect Immun; 2009 Jun; 77(6):2499-507. PubMed ID: 19332531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bordetella adenylate cyclase toxin differentially modulates toll-like receptor-stimulated activation, migration and T cell stimulatory capacity of dendritic cells.
    Adkins I; Kamanova J; Kocourkova A; Svedova M; Tomala J; Janova H; Masin J; Chladkova B; Bumba L; Kovar M; Ross PJ; Tuckova L; Spisek R; Mills KH; Sebo P
    PLoS One; 2014; 9(8):e104064. PubMed ID: 25084094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.
    Simsova M; Sebo P; Leclerc C
    Int J Med Microbiol; 2004 Apr; 293(7-8):571-6. PubMed ID: 15149033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.